| scholarly article | Q13442814 |
| P50 | author | Jodi A Flaws | Q63198198 |
| P2093 | author name string | Ali Entezam | |
| Gloria E Hoffman | |||
| Wei Wei Le | |||
| Karen Usdin | |||
| Noriyuki Otsuka | |||
| John H McDonald | |||
| Lawrence Nelson | |||
| Sanjeeda Jafar | |||
| Zhi-Bin Tong | |||
| P2860 | cites work | The zona pellucida: using molecular genetics to study the mammalian egg coat | Q28139046 |
| From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome | Q28247567 | ||
| Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome | Q28273791 | ||
| Ablation of the Sam68 gene impairs female fertility and gonadotropin-dependent follicle development | Q28294438 | ||
| The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome | Q28507736 | ||
| Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance | Q28513538 | ||
| Hormone-induced proliferation and differentiation of granulosa cells: a coordinated balance of the cell cycle regulators cyclin D2 and p27Kip1 | Q28564876 | ||
| The zona pellucida: using molecular genetics to study the mammalian egg coat | Q29013390 | ||
| Isolation of a human DNA sequence which spans the fragile X. | Q33373107 | ||
| Studies of FRAXA and FRAXE in women with premature ovarian failure | Q33681082 | ||
| Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel. | Q34044314 | ||
| Premature ovarian failure and the FMR1 gene | Q34216982 | ||
| Premature ovarian failure in the fragile X syndrome | Q34306135 | ||
| Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations. | Q34364858 | ||
| Fragile X syndrome: a model of gene-brain-behavior relationships | Q34396131 | ||
| Impairment of proteasome structure and function in aging. | Q34801742 | ||
| CGG-repeat length threshold for FMR1 RNA pathogenesis in a cellular model for FXTAS | Q34955465 | ||
| Ubiquitin-proteasome pathway and cellular responses to oxidative stress | Q35027877 | ||
| Predictors and risk model development for menopausal age in fragile X premutation carriers | Q35093727 | ||
| Altered hypothalamus-pituitary-adrenal gland axis regulation in the expanded CGG-repeat mouse model for fragile X-associated tremor/ataxia syndrome | Q35533280 | ||
| Quantitative comparison of FMR1 gene expression in normal and premutation alleles | Q35643830 | ||
| Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain. | Q35869366 | ||
| Regional FMRP deficits and large repeat expansions into the full mutation range in a new Fragile X premutation mouse model | Q35944748 | ||
| Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome. | Q36014935 | ||
| Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems | Q36897434 | ||
| Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women | Q37058031 | ||
| Messenger RNA for neuropeptide Y in the arcuate nucleus increases in parallel with plasma adrenocorticotropin during sepsis in the rat | Q37181098 | ||
| Ectopic expression of CGG containing mRNA is neurotoxic in mammals | Q37223278 | ||
| The fragile X syndrome repeats form RNA hairpins that do not activate the interferon-inducible protein kinase, PKR, but are cut by Dicer | Q37369000 | ||
| Genetically modified mouse models for premature ovarian failure (POF). | Q37566710 | ||
| The ubiquitous role of ubiquitin in the DNA damage response | Q37807639 | ||
| Ovarian structure in cases of primary and secondary infertility. | Q38998079 | ||
| Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients | Q40117267 | ||
| RNA-binding proteins hnRNP A2/B1 and CUGBP1 suppress fragile X CGG premutation repeat-induced neurodegeneration in a Drosophila model of FXTAS. | Q42975231 | ||
| Effect of bcl-2 on the primordial follicle endowment in the mouse ovary | Q43458001 | ||
| Suckling stimulus suppresses messenger RNA for tyrosine hydroxylase in arcuate neurons during lactation | Q43739600 | ||
| Alterations in peripheral concentrations of inhibin A in cattle studied using a time-resolved immunofluorometric assay: relationship with estradiol and follicle-stimulating hormone in various reproductive conditions | Q44038689 | ||
| FMR1 premutation carrier frequency in patients undergoing routine population-based carrier screening: insights into the prevalence of fragile X syndrome, fragile X-associated tremor/ataxia syndrome, and fragile X-associated primary ovarian insuffici | Q44165815 | ||
| Induction of inclusion formation and disruption of lamin A/C structure by premutation CGG-repeat RNA in human cultured neural cells | Q45031515 | ||
| Evidence of early ovarian aging in fragile X premutation carriers | Q45050634 | ||
| Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers | Q46124789 | ||
| RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila | Q47071910 | ||
| Size-frequency analysis of atresia in cycling rats | Q47180417 | ||
| Olfactory and vomeronasal deafferentation of male hamsters: histological and behavioral analyses | Q48292965 | ||
| Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology | Q48406116 | ||
| Changes in hypothalamic corticotropin-releasing hormone, neuropeptide Y, and proopiomelanocortin gene expression during chronic rapid eye movement sleep deprivation of rats | Q48530848 | ||
| Ovarian reserve determinations suggest new function of FMR1 (fragile X gene) in regulating ovarian ageing | Q48701983 | ||
| Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary | Q48868225 | ||
| Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. | Q51965229 | ||
| Implications of the FMR1 gene in menopause: study of 147 Spanish women. | Q51968564 | ||
| Association between idiopathic premature ovarian failure and fragile X premutation. | Q51978995 | ||
| Clinical involvement and protein expression in individuals with the FMR1 premutation. | Q52169510 | ||
| Is early natural menopause a biologic marker of health and aging? | Q54783693 | ||
| Stathmokinetic analysis of granulosa cell proliferation in antral follicles of cyclic rats | Q70795552 | ||
| FRAXA premutation associated with premature ovarian failure | Q71621167 | ||
| Imminent oocyte exhaustion and reduced follicular recruitment mark the transition to acyclicity in aging C57BL/6J mice | Q71702598 | ||
| A longitudinal study of estrous cyclicity in aging C57BL/6J mice: I. Cycle frequency, length and vaginal cytology | Q71840590 | ||
| Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse | Q74060519 | ||
| Premature ovarian failure and fragile X premutation: a study on 45 women | Q75345114 | ||
| Twinning and premature ovarian failure in premutation fragile X carriers | Q77339395 | ||
| Pathological changes in the reproductive organs of cows and heifers culled because of infertility | Q78540999 | ||
| Estimation of nuclear population from microtome sections | Q82126847 | ||
| X chromosome inactivation does not define the development of premature ovarian failure in fragile X premutation carriers | Q82647770 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 439-456 | |
| P577 | publication date | 2012-04-02 | |
| P1433 | published in | Journal of Histochemistry and Cytochemistry | Q1523992 |
| P1476 | title | Ovarian abnormalities in a mouse model of fragile X primary ovarian insufficiency | |
| P478 | volume | 60 |
| Q33617701 | Association of skewed X-chromosome inactivation with FMR1 CGG repeat length and anti-Mullerian hormone levels: a cohort study |
| Q35541848 | Curvilinear association of CGG repeats and age at menopause in women with FMR1 premutation expansions |
| Q40697612 | Early decline in functional ovarian reserve in young women with low (CGGn < 26) FMR1 gene alleles |
| Q34074523 | Expression of an expanded CGG-repeat RNA in a single pair of primary sensory neurons impairs olfactory adaptation in Caenorhabditis elegans |
| Q37451133 | FMR1 CGG expansions: prevalence and sex ratios |
| Q37115382 | FMR1-dependent variability of ovarian aging patterns is already apparent in young oocyte donors |
| Q36151280 | FMRP Associates with Cytoplasmic Granules at the Onset of Meiosis in the Human Oocyte |
| Q59806856 | Fragile X Associated Primary Ovarian Insufficiency (FXPOI): Case Report and Literature Review |
| Q36375813 | Fragile X premutation RNA is sufficient to cause primary ovarian insufficiency in mice |
| Q39375765 | Fragile X syndrome: an overview and update of the FMR1 gene. |
| Q37524454 | Fragile X-associated tremor/ataxia syndrome (FXTAS): pathology and mechanisms |
| Q36946491 | Granulosa cell and oocyte mitochondrial abnormalities in a mouse model of fragile X primary ovarian insufficiency. |
| Q34106386 | How the FMR1 gene became relevant to female fertility and reproductive medicine |
| Q90699685 | In silico, in vitro, and in vivo Approaches to Identify Molecular Players in Fragile X Tremor and Ataxia Syndrome |
| Q33786496 | Intermediate CGG repeat length at the FMR1 locus is not associated with hormonal indicators of ovarian age. |
| Q38605681 | Molecular insights into the aetiology of female reproductive ageing. |
| Q34055453 | Mouse models of the fragile X premutation and fragile X-associated tremor/ataxia syndrome |
| Q41258345 | Newborn screening for fragile X syndrome |
| Q47556307 | Premature recruitment of oocyte pool and increased mTOR activity in Fmr1 knockout mice and reversal of phenotype with rapamycin |
| Q36368705 | Presence of inclusions positive for polyglycine containing protein, FMRpolyG, indicates that repeat-associated non-AUG translation plays a role in fragile X-associated primary ovarian insufficiency |
| Q37586512 | Quantifying growing versus non-growing ovarian follicles in the mouse |
| Q33732476 | RNA-binding proteins in human oogenesis: Balancing differentiation and self-renewal in the female fetal germline |
| Q49905433 | Repeat-associated non-AUG (RAN) translation and other molecular mechanisms in Fragile X Tremor Ataxia Syndrome. |
| Q41144516 | Reproductive and gynecologic care of women with fragile X primary ovarian insufficiency (FXPOI). |
| Q27324731 | Skin-derived mesenchymal stem cells help restore function to ovaries in a premature ovarian failure mouse model |
| Q36472667 | Somatic expansion in mouse and human carriers of fragile X premutation alleles |
| Q28077015 | Study of the Genetic Etiology of Primary Ovarian Insufficiency: FMR1 Gene |
| Q27026782 | The FMR1 gene, infertility, and reproductive decision-making: a review |
| Q48577134 | The Stage- and Cell Type-Specific Localization of Fragile X Mental Retardation Protein in Rat Ovaries |
| Q42398270 | The importance of redundancy of functional ovarian reserve when investigating potential genetic effects on ovarian function |
| Q34077084 | Understanding decreased fertility in women carriers of the FMR1 premutation: a possible mechanism for Fragile X-Associated Primary Ovarian Insufficiency (FXPOI). |
| Q89172366 | Use of human-derived stem cells to create a novel, in vitro model designed to explore FMR1 CGG repeat instability amongst female premutation carriers |
| Q21198724 | Use of model systems to understand the etiology of fragile X-associated primary ovarian insufficiency (FXPOI) |
Search more.